Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: A Study of TIL in Advanced Solid Tumors (DFGD) [EARLY_Phase 1]
An early Phase 1 trial evaluating tumor-infiltrating lymphocytes (TIL) therapy in patients with advanced solid tumors. Recruitment is ongoin…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body [Phase 1, Phase 2]
First-in-human Phase 1/2 trial evaluating REGN10597 alone or with cemiplimab in adults with melanoma, clear-cell renal cell carcinoma, and o…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: A Phase I Study, Evaluating the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors [Phase 1]
Phase I trial evaluating PRJ1-3024 for safety, pharmacokinetics, and preliminary efficacy in patients with advanced solid tumors. The study …
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer [NA]
A Mayo Clinic-sponsored trial is evaluating Acceptance and Commitment Therapy and compassionate-based virtual group therapy to improve psych…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Exploratory Clinical Study on Memory NK Cell Therapy for Advanced Metastatic Solid Tumors [Phase 1, Phase 2]
An exploratory Phase 1/2 clinical trial is evaluating memory NK cell therapy in patients with advanced solid tumors. The study is currently …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: A Study of DS3610a in Participants With Advanced Solid Tumor [Phase 1]
A Phase 1 clinical trial update for DS3610a in participants with advanced solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer Cachexia [Phase 1]
This clinical trial update describes a Phase I study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of SXRN…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy
This pilot prospective clinical trial uses remote monitoring for cancer patients undergoing outpatient chemotherapy and is currently recruit…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Social Emotional Development in Young Children With Cancer
An update on a St. Jude trial studying social-emotional development in young children with cancer; the study is currently active but not rec…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: PRaG-1 Plus PRaG Therapy in Advanced Solid Tumors: A Prospective Clinical Trial (PRaG 10.0) [Phase 2]
Phase 2 prospective clinical trial evaluating PRaG-1 plus PRaG Therapy in advanced solid tumors; the trial is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors. [Phase 1]
A Phase 1 clinical trial evaluating ERAS-4001 in patients with advanced or metastatic solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: PAS-004 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial of PAS-004 in patients with advanced solid tumors is currently recruiting, with eligibility including tumors bearing RAS, NF…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: FMT With Nivolumab in Patients With Advanced Solid Cancers Who Have Progressed During Anti-PD-(L)1 Therapy [NA]
This clinical trial update describes a study evaluating fecal microbiota transplantation (FMT) with nivolumab for patients with advanced sol…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Safety and Efficacy of Combining a Vitamin B6-Limited Diet With Immunotherapy in Solid Tumor Patients: A Clinical Study Protocol [Phase 1]
A Phase 1 study protocol evaluating the safety and potential efficacy of combining a vitamin B6-limited diet with immunotherapy in patients …
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy [NA]
This ClinicalTrials.gov entry describes a pediatric stem cell transplant and cellular therapy trial evaluating a family health communication…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Personalized Neoantigen Peptide Vaccines for Solid Tumors [Phase 1, Phase 2]
Seqker Biosciences is running a Phase 1/Phase 2 trial of personalized neoantigen peptide vaccines for solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors [Phase 1, Phase 2]
Clinical trial update: A phase 1/2 study evaluating RC278 for safety and efficacy in patients with solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors [Phase 1]
A Phase 1 clinical study evaluating BioTTT001 for safety and preliminary efficacy in patients with malignant solid tumors, currently enrolli…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values [NA]
Memorial Sloan Kettering Cancer Center is conducting a trial to adapt an intervention that discusses and shares adults' health-related value…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor [Phase 1]
A Phase 1 trial is evaluating a KRAS-targeted T cell receptor gene-engineered T cell therapy for patients with advanced solid tumors and is …
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors. [Phase 1]
Phase 1 trial evaluating OMTX705 as a monotherapy and in combination with an anti-PD-1 therapy in patients with advanced solid tumors; curre…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor [Phase 1]
This Phase 1 clinical trial evaluates a T cell receptor-engineered T cell therapy targeting KRAS mutations in patients with advanced solid t…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors [Phase 1]
Open-label, multi-center Phase I/IIa dose-escalation study to evaluate the safety, tolerability, pharmacokinetic profile and preliminary eff…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers. [Phase 2, Phase 3]
This clinical trial update describes Arm 03 of the DETERMINE trial evaluating entrectinib in adults, pediatric, and teenage/young adult pati…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating repotrectinib in pediatric and young adult patients with ALK, ROS1, or NTRK1-3 alterations in locally …